PRFX

PRFX

Painreform Ltd

Rev —top 1%5Y
Hold

PainReform Ltd develops reformulated pain management solutions, notably PRF-110, a viscous oil-based anesthetic for post-surgical pain relief, aiming to reduce opioid use. The company focuses on enhancing the efficacy and safety of established therapeutics.

⚕️ Healthcare NASDAQ Listed 2020 $ USD
$1,000 invested 5 years ago $0today

Score Overview

1 Year
Score
Net Growth66.84%
Net TrendGrew
Net Income Consistency
Rev Growth
Rev TrendGrew
Revenue Consistency
5 Years
Score
Net Growth-19.37%
Net Trend20%
Net Income Consistency
Rev Growth
Rev Trend40%
Revenue Consistency
All Time
Score
Net Growth-19.37%
Net Trend20%
Net Income Consistency
Rev Growth
Rev Trend40%
Revenue Consistency

See the full market ranking →

Painreform Ltd fundamental performance

Across Painreform Ltd's full reported history, from 2020 to 2025, revenue grew from $ 0.00 to $ 17K and net income went from -$ 4M to -$ 4M. Revenue increased in 40% of the years measured; net income in 20%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 1.03
1 Year2025-08-12
$ 6.77-84.78%
5 Years2021-08-12
$ 3.2K-99.97%
All Time2020-09-01
$ 8.09K-99.99%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2025$ 17K-$ 4M$ 4M
2024$ 0.00-$ 14M$ 4M
2023$ 0.00-$ 9M$ 8M
2022$ 86K-$ 8M$ 4M
2021$ 0.00-$ 7M$ 16M
IPO2020$ 0.00-$ 4M$ 15M

Explore beyond PRFX

You're looking at Painreform Ltd. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies